SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-23-016996
Filing Date
2023-03-03
Accepted
2023-03-03 06:02:06
Documents
14
Period of Report
2023-03-02
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea174602-8k_cormedix.htm   iXBRL 8-K 24621
2 PRESS RELEASE ISSUED MARCH 2, 2023 ea174602ex99-1_cormedix.htm EX-99.1 17507
3 GRAPHIC image_001.jpg GRAPHIC 5271
  Complete submission text file 0001213900-23-016996.txt   229231

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE crmd-20230302.xsd EX-101.SCH 3227
5 XBRL LABEL FILE crmd-20230302_lab.xml EX-101.LAB 34240
6 XBRL PRESENTATION FILE crmd-20230302_pre.xml EX-101.PRE 22359
8 EXTRACTED XBRL INSTANCE DOCUMENT ea174602-8k_cormedix_htm.xml XML 3593
Mailing Address 300 CONNELL DRIVE SUITE 4200 BERKELEY HEIGHTS NJ 07922
Business Address 300 CONNELL DRIVE SUITE 4200 BERKELEY HEIGHTS NJ 07922 908-517-9500
CorMedix Inc. (Filer) CIK: 0001410098 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34673 | Film No.: 23701560
SIC: 2834 Pharmaceutical Preparations